NASDAQ:ZIVO ZIVO Bioscience (ZIVO) Stock Forecast, Price & News $1.22 -0.06 (-4.69%) (As of 08:00 AM ET) Add Compare Share Share Today's Range$1.22▼$1.2250-Day Range$1.18▼$2.0952-Week Range$1.10▼$3.75Volume100 shsAverage Volume11,886 shsMarket Capitalization$12.75 millionP/E RatioN/ADividend YieldN/APrice Target$6.00 ProfileProfileAnalyst RatingsChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media ZIVO Bioscience MarketRank™ ForecastAnalyst Rating0.00 Rating ScoreUpside/Downside368.8% Upside$6.00 Price TargetShort InterestHealthy0.69% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.07 out of 5 starsMedical Sector559th out of 975 stocksBiological Products, Except Diagnostic Industry83rd out of 158 stocks 2.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of $6.00, ZIVO Bioscience has a forecasted upside of 368.8% from its current price of $1.28.Amount of Analyst CoverageZIVO Bioscience has received no research coverage in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.69% of the float of ZIVO Bioscience has been sold short.Short Interest Ratio / Days to CoverZIVO Bioscience has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in ZIVO Bioscience has recently decreased by 8.84%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldZIVO Bioscience does not currently pay a dividend.Dividend GrowthZIVO Bioscience does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ZIVO. Previous Next 2.6 News and Social Media Coverage News SentimentZIVO Bioscience has a news sentiment score of 0.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for ZIVO Bioscience this week, compared to 0 articles on an average week.Search Interest1 people have searched for ZIVO on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added ZIVO Bioscience to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ZIVO Bioscience insiders have not sold or bought any company stock.Percentage Held by Insiders13.40% of the stock of ZIVO Bioscience is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 14.12% of the stock of ZIVO Bioscience is held by institutions. Previous Next N/A Earnings and Valuation Previous Next See Top Rated MarketRank™ Stocks Here About ZIVO Bioscience (NASDAQ:ZIVO) StockZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.Read More ZIVO Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ZIVO Stock News HeadlinesOctober 3, 2023 | finance.yahoo.comZIVO Bioscience to Present at the Dawson James Small Cap Growth ConferenceSeptember 19, 2023 | finance.yahoo.comTrial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler ChickensOctober 3, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. August 16, 2023 | businesswire.comZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife ™ Algal Biomass Product Produced Over the Next 18 MonthsAugust 16, 2023 | marketwatch.comZivo Bioscience: ZWorldwide to Buy All Zivolife Supply for First 18 Months of AgreementAugust 16, 2023 | finance.yahoo.comZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 MonthsJuly 26, 2023 | finance.yahoo.comZIVO Commences Sales of its Proprietary Algal Biomass as Human FoodJune 29, 2023 | marketwatch.comZivo Bioscience Shares Jump Premarket After Dropping Plans for Securities OfferingOctober 3, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. May 30, 2023 | benzinga.comZIVO's GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food IngredientMay 30, 2023 | finance.yahoo.comZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food IngredientMay 10, 2023 | investing.comSK Bioscience Co Ltd (302440)April 5, 2023 | msn.comZivo Bioscience gets $1M loan from CEOMarch 17, 2023 | markets.businessinsider.comMaxim Group Keeps Their Buy Rating on Zivo Bioscience (ZIVO)February 10, 2023 | marketwatch.comZivo Bio Shares Slide 23% on High Mortality Rate in Coccidiosis Treatment StudyFebruary 10, 2023 | marketwatch.comStocks to Watch: Blue Apron, Zivo Bioscience, Berkshire GreyFebruary 10, 2023 | markets.businessinsider.comZIVO Reports Negative Results Of Study With Product Candidate For Coccidiosis Treatment In ChickensJanuary 29, 2023 | seekingalpha.comPressure BioSciences, One World team up to develop CBD sports performance drinksOctober 25, 2022 | finance.yahoo.comZIVO Bioscience Announces Plans for a New Streamlined, Focused Corporate Structure and Establishes the ZIVOLife Agtech BusinessSeptember 23, 2022 | finance.yahoo.comZIVO Bioscience CEO Issues Letter to ShareholdersSeptember 16, 2022 | finance.yahoo.comZIVO Bioscience, Inc. (ZIVO)August 10, 2022 | finance.yahoo.comZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis TreatmentJune 27, 2022 | finance.yahoo.comZivo Bioscience Joins Russell Microcap® IndexApril 25, 2022 | seekingalpha.comZIVO Bioscience regains compliance with Nasdaq continued listing ruleApril 25, 2022 | apnews.comZivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from NasdaqJanuary 10, 2022 | seekingalpha.comZIVO Bioscience names John Payne as president, CEOJanuary 10, 2022 | finance.yahoo.comZIVO Bioscience Names Chairman John B. Payne as President and CEOSee More Headlines Receive ZIVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ZIVO Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address ZIVO Company Calendar Last Earnings5/11/2020Today10/03/2023Next Earnings (Estimated)10/05/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ZIVO Previous SymbolOTCMKTS:HEPI CUSIPN/A CIK1101026 Webwww.zivobioscience.com Phone(248) 452-9866FaxN/AEmployees8Year FoundedN/APrice Target and Rating Average Stock Price Forecast$6.00 High Stock Price Forecast$6.00 Low Stock Price Forecast$6.00 Forecasted Upside/Downside+368.8%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,740,000.00 Net MarginsN/A Pretax Margin-214,543.19% Return on Equity-1,249.74% Return on Assets-438.17% Debt Debt-to-Equity RatioN/A Current Ratio0.14 Quick Ratio0.14 Sales & Book Value Annual Sales$20,000.00 Price / Sales668.80 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares10,450,000Free Float9,050,000Market Cap$13.38 million OptionableNot Optionable Beta0.24 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. John B. Payne (Age 75)Pres, CEO & Chairman Comp: $572.75kMr. Keith R. Marchiando (Age 61)CFO, Treasurer & Sec. Comp: $362.5kDr. Harlan L. Miller IIIVP of Technology & Global SupplyKey CompetitorsEiger BioPharmaceuticalsNASDAQ:EIGROrganovoNASDAQ:ONVOEloxx PharmaceuticalsNASDAQ:ELOXSurrozenNASDAQ:SRZNAvalon GloboCareNASDAQ:ALBTView All CompetitorsInsidersNola E MastersonBought 300 shares on 12/19/2022Total: $792.00 ($2.64/share)View All Insider Transactions ZIVO Stock - Frequently Asked Questions What is ZIVO Bioscience's stock price forecast for 2023? 0 analysts have issued twelve-month price targets for ZIVO Bioscience's stock. Their ZIVO share price forecasts range from $6.00 to $6.00. On average, they predict the company's stock price to reach $6.00 in the next year. This suggests a possible upside of 368.8% from the stock's current price. View analysts price targets for ZIVO or view top-rated stocks among Wall Street analysts. How have ZIVO shares performed in 2023? ZIVO Bioscience's stock was trading at $2.50 at the beginning of 2023. Since then, ZIVO shares have decreased by 48.8% and is now trading at $1.28. View the best growth stocks for 2023 here. When is ZIVO Bioscience's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, October 5th 2023. View our ZIVO earnings forecast. How were ZIVO Bioscience's earnings last quarter? ZIVO Bioscience, Inc. (NASDAQ:ZIVO) released its quarterly earnings data on Monday, May, 11th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter. The biotechnology company earned $0.02 million during the quarter. What is ZIVO Bioscience's stock symbol? ZIVO Bioscience trades on the NASDAQ under the ticker symbol "ZIVO." How do I buy shares of ZIVO Bioscience? Shares of ZIVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is ZIVO Bioscience's stock price today? One share of ZIVO stock can currently be purchased for approximately $1.28. How much money does ZIVO Bioscience make? ZIVO Bioscience (NASDAQ:ZIVO) has a market capitalization of $13.38 million and generates $20,000.00 in revenue each year. How can I contact ZIVO Bioscience? ZIVO Bioscience's mailing address is 2804 ORCHARD LAKE ROAD SUITE 202, KEEGO HARBOR MI, 48320. The official website for the company is www.zivobioscience.com. The biotechnology company can be reached via phone at (248) 452-9866 or via email at investor@zivobioscience.com. This page (NASDAQ:ZIVO) was last updated on 10/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZIVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.